Company Overview
- Headquarters
- 4340 Duncan Ave St., Louis MO
- Website
- c2ndiagnostics.com
- Phone
- (314) 633-1884
- Employees
- 90
- Founded in
- 2007
- Industry
- BioTech/Drugs
- NAICS Code
-
NAICS Code 541 CompaniesNAICS Code 54 CompaniesNAICS Code 541714 CompaniesNAICS Code 54171 CompaniesNAICS Code 5417 Companies
- SIC Code
-
SIC Code 87 CompaniesSIC Code 873 Companies
Financials & Stats
Revenue
$50B
Who is C2N Diagnostics
C2N Diagnostics is a biotechnology company based in St. Louis, Missouri. The company is focused on developing diagnostic tests for neurological disorders. C2N Diagnostics employs 90 people and generates approximately $50 million in revenue. C2N Diagnostics specializes in developing blood tests for neurological disorders, particularly Alzheimer's disease. Their flagship product, PrecivityAD™, is a blood test that measures amyloid beta proteins, which are associated with Alzheimer's disease. The company's tests are designed to be accessible and cost-effective, providing a valuable tool for physicians in diagnosing and managing Alzheimer's disease. C2N Diagnostics' PrecivityAD™ test has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) and has achieved the CE Mark from the European Union. This recognition highlights the test's potential to significantly impact the diagnosis and treatment of Alzheimer's disease. For more information about C2N Diagnostics and their products, please visit www.c2ndiagnostics.com.
Company Leadership
C2N Diagnostics Tech Stack
Companies Similar to C2N Diagnostics
Analyze industry trends and opportunities by examining competitors and companies comparable to C2N Diagnostics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 50M | Cambridge, MA | |||
| 50M | 59 | Foster City, CA | ||
| 50M | 74 | San Diego, CA | ||
| 50M | 181 | New Haven, CT | 2017 | |
| 50M | 58 | Carlsbad, CA |